Payers

In Big Win for JDRF’s Coverage2Control Campaign, Anthem Decides to Cover Artificial Pancreas Systems

November 22, 2017

— America’s 25 largest health insurers now all cover this breakthrough diabetes technology NEW YORK, November 17, 2017 – JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced that its Coverage2Control campaign swayed Anthem, America’s second-largest health insurance company, to cover artificial pancreas (AP) systems. Anthem changed its policy after engaging […]

Cardinal Health Launches Opioid Action Program to Support Drug Abuse Prevention and Education in Appalachia

November 16, 2017

Company to Collaborate with Key Partners across Ohio, Kentucky, Tennessee and West Virginia DUBLIN, Ohio, Nov. 16, 2017 /PRNewswire/ — Cardinal Health (NYSE: CAH) today launched its new Opioid Action Program, aimed at helping communities in four of the nation’s hardest-hit states across Appalachia combat the opioid epidemic. The pilot program will deliver much needed […]

US Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics

November 13, 2017

–-PGDx’s Pan-Cancer Profiling Panels with MSI Testing for Immuno-Oncology Applications Are Now Available Nationwide to Cancer Patients Treated at the VA–                                                                                                   –PGDx’s CancerSELECTTM 125 Offers Comprehensive Tissue-Based Tumor Profiling and Its PlasmaSELECTTM 64 Is First Liquid Biopsy Assay Available to Patients at VA Facilities— BALTIMORE, MD –Personal Genome Diagnostics Inc. (PGDx) today announced the renewal […]

Verma Outlines Vision for Medicaid, Announces Historic Steps Taken to Improve the Program

November 9, 2017

Today, Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma discussed her vision for the future of Medicaid and unveiled new CMS policies that encourage states to propose innovative Medicaid reforms, reduce federal regulatory burdens, increase efficiency, and promote transparency and accountability during a plenary session at the National Association of Medicaid Directors (NAMD) […]

Surescripts Joins Epic, CVS to Deliver Drug Pricing Info in EHRs

November 9, 2017

Surescripts announced an effort to increase transparency around prescription drug benefits and pricing. Working with EHR vendors and pharmacy benefit managers, Surescripts will provide real-time patient-specific benefit and price information to providers at the point of care. Once integrated with the EHR, patients and doctors will also be able to see information and pricing on […]

Public-Private Partnerships to Bridge Demand-Supply Gap in Saudi’s Healthcare Sector

November 1, 2017

Government expenditure on healthcare across the globe is growing at a pace that is unlikely to be sustainable unless new funding sources are found. As this reality dawns, governments around the world are increasingly looking to Public Private Partnerships  (PPPs) to build effective healthcare systems. While providing healthcare is largely recognised as the responsibility of […]

CX: Pharma’s search for excellence

October 25, 2017

The term customer experience (CX) might be relatively new in pharma but the reality is as old as the industry itself. Every time a company interacts with a customer, it is delivering some sort of customer experience. In our increasingly multi-stakeholder and multichannel world, pharma companies must get comfortable with the idea that CX is not a linear, […]

Connected Health Conference

October 17, 2017

The Connected Life Journey: Shaping Health and Wellness for Every Generation The 2017 Connected Health Conference (CHC17) is the most anticipated event in connected health, bringing together the industry’s two leading events and top thought leaders for three days of inspirational, provocative and forward-thinking discussion. Plus, it’s now in Boston  — learn more about the […]

Data-Driven Patient Outreach

October 17, 2017

How Properly Timed, Targeted Engagement Tactics can Increase Adherence and Brand Revenue Co-pay savings programs are powerful brand marketing tools; not just because of their ability to introduce new patients to therapy, but also due to the wealth of patient behavior data that they generate. These data, when used properly, can drive targeted patient engagement strategies that are uniquely […]

First-in-class BRCA-positive Ovarian Cancer Medicine Lynparza® (olaparib) Receives Positive pan-Canadian Oncology Drug Review (pCODR) Recommendation for Provincial Reimbursement

September 21, 2017

MISSISSAUGA, ON, Sept. 21, 2017 /CNW/ – AstraZeneca Canada is pleased to announce that the pan-Canadian Oncology Drug Review (pCODR) has provided an overwhelmingly positive clinical recommendation for the reimbursement of Lynparza® (olaparib), a first-of-its-kind treatment for BRCA-mutated ovarian cancer.1 Lynparza is an oral, potent inhibitor of poly (ADP-ribose) polymerase (PARP) available as a maintenance […]

Amgen and Humana Partner For Improved Health Outcomes And Efficiency

August 23, 2017

Two of the nation’s leading health organizations, health and well-being company Humana Inc. (NYSE: HUM) and biotechnology company Amgen (NASDAQ:AMGN), have teamed up to identify opportunities to improve health outcomes and improve efficiency by unlocking new insights from the real world health care experiences of Humana’s 13 million members. In the collaboration agreement between Amgen […]

Humana, Amgen to Collaborate On Data-Backed Care Research

August 23, 2017

Humana and Amgen are collaborating on an effort to use data and real-world evidence to find ways to improve health outcomes and improve provider efficiency. The agreement between Humana, a health plan administrator, and Amgen, a biotechnology company, will initially focus on six medical conditions that are widespread and expensive to treat. First to be […]

EndoPredict® Receives Positive Coverage Decisions From Medicare and Anthem Brings Total Coverage to Over 90 Percent of Breast Cancer Patients

August 18, 2017

SALT LAKE CITY, Aug. 17, 2017 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Palmetto GBA, the Medicare contractor who oversees the MolDx program and Anthem, Inc., one of the largest private insurers in the country, have announced positive coverage decisions for EndoPredict® testing.   […]

NICE Recommends Erbitux® in Combination with Platinum-Based Chemotherapy for the Treatment of Recurrent and/or Metastatic Head and Neck Cancer in the Oral Cavity

August 8, 2017

DARMSTADT, Germany, August 8, 2017 /PRNewswire/ —   Not intended for U.K./U.S. based media   Decision secures access to Erbitux® for new patients in England with oral cavity tumors All patients currently receiving Erbitux® will have continued access Merck, a leading science and technology company, announced today that the National Institute for Health and Care […]

CVS formulary knocks Lilly, BI’s Jardiance in favor of Johnson & Johnson’s Invokana

August 3, 2017

Right on the heels of Express Scripts’ 2018 formulary release, rival PBM giant CVS Caremark has published its list of which drugs are in and which are out.   In the SGLT2 class of meds to treat diabetes, CVS removed Eli Lilly and Boehringer Ingelheim’s Jardiance and added Johnson & Johnson’s Invokana as a preferred […]

FEEDBACK